The Board has remanded the case due to insufficient medical opinions regarding the relationship between the Veteran's exposure to contaminated water at Camp Lejeune and his development of primary sclerosing cholangitis, which may have contributed to his metastatic gallbladder cancer.
The deciding factor: The Board is seeking clarification on whether the Veteran's exposure to contaminated water at Camp Lejeune caused or contributed to his development of primary sclerosing cholangitis and subsequent metastatic gallbladder cancer.
- Claimed conditions
- metastatic cholangiocarcinoma, primary sclerosing cholangitis
- How they argued it
- Not specified
- Exposure basis
- Camp Lejeune water
- Rating
- Not verified here — check the original decision
- Decision date
- August 10, 2022
- Citation
- 22045402
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 22045402.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board has determined that the VA did not fully develop the claim for all of the Veteran's possible participation in TERA, including unrecorded trips to countries neighboring Vietnam and service with Republic of Korea forces by Navy personnel involved in the Poseidon program. The case is being remanded to obtain this information.
- Whole decision: Granted
The Board has granted service connection for colitis, primary sclerosing cholangitis, and cholangiocarcinoma as secondary to the Veteran's service-connected vitiligo.
- Whole decision: Denied
The Board denied service connection for the cause of the Veteran's death, as metastatic cholangiocarcinoma was not shown to be related to his active service.
- Whole decision: Denied
The Board denied payment or reimbursement for non-VA medical care for cancer and hepatic steatosis as a Camp Lejeune family member due to the clinical finding that these conditions did not result from exposure at Camp Lejeune.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.